Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 518.78 +16.33 (+3.25%) Streaming Delayed Price Updated: 1:55 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 ... 9 10 11 12 13 14 15 16 17 ... 53 54 Next > Where Will Vertex Pharmaceuticals Be in 10 Years? January 25, 2024 As the adage goes, winners keep winning. Via The Motley Fool Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals? January 25, 2024 It's always tough to be compared to a giant. Via The Motley Fool Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January January 25, 2024 These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions. Via InvestorPlace Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts January 24, 2024 UBS insights on Biogen Inc's challenges with Leqembi in the Alzheimer's market. Analyst downgrades, revised sales estimates, and CEO's growth strategy. Via Benzinga Where Will CRISPR Therapeutics Be in 5 Years? January 24, 2024 The company could maintain the momentum it gained last year. Via The Motley Fool Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday January 24, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings January 23, 2024 Via Benzinga Market Whales and Their Recent Bets on VRTX Options January 17, 2024 Via Benzinga 2 Super Stocks You'll Wish 5 Years From Now That You'd Bought Today January 24, 2024 These powerhouse stocks still have plenty of growth catalysts to tap into over the coming years. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session January 23, 2024 Via Benzinga 1 Setback and 1 Opportunity for CRISPR Therapeutics Stock January 23, 2024 Despite A bump in the road, the biotech's future looks sunny. Via The Motley Fool 2 gene editing stocks to keep on your 2024 watchlist January 23, 2024 Gene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Via MarketBeat Exposures Product Safety Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024 January 22, 2024 Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. Via Talk Markets The Best Stock to Invest $1,000 in Right Now January 17, 2024 This stock has what it takes to be a big winner. Via The Motley Fool A New S&P 500 Bull Market Just Began: 3 No-Brainer Stocks to Buy Hand Over Fist January 22, 2024 These stocks seem likely to keep up their winning ways. Via The Motley Fool Topics Stocks Exposures US Equities 10 Health Care Stocks Whale Activity In Today's Session January 22, 2024 Via Benzinga Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today January 22, 2024 Via Benzinga If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today January 22, 2024 Has investing in Vertex been a better option than just putting your money in the S&P 500? Via The Motley Fool Topics Stocks Exposures US Equities Cathie Wood's Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks January 22, 2024 The flagship ETF's top holdings are down in 2024, especially No. 1 Coinbase. Via Investor's Business Daily Topics ETFs 2 Smart Growth Stocks to Buy Hand Over Fist in 2024 January 21, 2024 These businesses are on paths to extremely bright futures. Via The Motley Fool 3 Unstoppable Growth Stocks That Can Make You Richer in 2024 January 20, 2024 These big winners of 2023 could keep their momentum going in the new year. Via The Motley Fool These 2 Phenomenal Growth Stocks Can Make You Richer in 2024 January 20, 2024 One market-beating stock and one beaten-down stock look like tempting buys for very different reasons. Via The Motley Fool 3 High-Flying Stocks That Could Soar Even More in 2024 January 20, 2024 These big winners could keep the momentum going. Via The Motley Fool Vertex to Announce Fourth Quarter and Full Year 2023 Financial Results on February 5 January 17, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule January 17, 2024 FDA approves CRISPR Therapeutics/Vertex's Casgevy a gene-edited cell therapy for transfusion-dependent beta-thalassemia. Vertex's swift launch strategy targets a network of treatment centers across the... Via Benzinga Exposures Product Safety Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock January 16, 2024 Shares of Vertex have risen exponentially since last month. Crispr stock, though, is meandering. Via Investor's Business Daily Vertex Announces US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia January 16, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session January 16, 2024 Via Benzinga Here's Why CRISPR Therapeutics Stock Rose 54% Last Year January 15, 2024 Key regulatory developments sent this biotech stock higher. Via The Motley Fool Down 88%, Could Editas Medicine Be a Good Investment Now? January 15, 2024 The past few years have been difficult ones, but shares of the gene editor are far more attractive now that a CRISPR medicine has passed regulatory hurdles. Via The Motley Fool < Previous 1 2 ... 9 10 11 12 13 14 15 16 17 ... 53 54 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
